Max Behrens

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Cross Sectional

Ejection Fraction

Patient Reported

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

David Rafei-Shamsabadi, Saskia Lehr, Max Behrens, Frank Meiss
Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy. Cancers 14 (3) (2022)